Biem R&D operates within the TÜBİTAK MARTEK Technology Development Zone, one of Türkiye’s leading innovation centers for health and life sciences. Located in a modern research facility covering approximately 400 square meters, the center provides an advanced environment for pharmaceutical research, process development, and technology innovation. Backed by extensive expertise in the development of solid, semi-solid, liquid, and oncology pharmaceutical formulations, Biem R&D designs and optimizes innovative manufacturing processes using internationally recognized Quality by Design (QbD) and Process Analytical Technology (PAT) approaches. Through its scientific capabilities, the center develops proprietary technologies and transfers them to pharmaceutical manufacturers through licensing and technology transfer agreements. With a multidisciplinary team of highly qualified scientists specializing in chemistry, pharmacy, and biology, Biem R&D is committed to advancing pharmaceutical innovation through scientific excellence, collaboration, and continuous improvement. As a dynamic and rapidly growing research organization, it serves as a trusted partner in pharmaceutical research, product development, and technology commercialization.